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Abstract
Background: To establish an efficient prophylaxis of coronary artery disease reliable risk stratification is
crucial, especially in the high risk population of patients suffering from diabetes mellitus. This prospective
study determined the predictive value of coronary calcifications for future cardiovascular events in
asymptomatic patients with diabetes mellitus.
Methods: We included 716 patients suffering from diabetes mellitus (430 men, 286 women, age 55.2 ±
15.2 years) in this study. On study entry all patients were asymptomatic and had no history of coronary
artery disease. In addition, all patients showed no signs of coronary artery disease in ECG, stress ECG or
echocardiography. Coronary calcifications were determined with the Imatron C 150 XP electron beam
computed tomograph. For quantification of coronary calcifications we calculated the Agatston score. After
a mean observation period of 8.1 ± 1.1 years patients were contacted and the event rate of cardiac death
(CD) and myocardial infarction (MI) was determined.
Results: During the observation period 40 patients suffered from MI, 36 patients died from acute CD.
The initial Agatston score in patients that suffered from MI or died from CD (475 ± 208) was significantly
higher compared to those without cardiac events (236 ± 199, p < 0.01). An Agatston score above 400 was
associated with a significantly higher annualised event rate for cardiovascular events (5.6% versus 0.7%, p
< 0.01). No cardiac events were observed in patients with exclusion of coronary calcifications. Compared
to the Framingham risk score and the UKPDS score the Agatston score showed a significantly higher
diagnostic accuracy in the prediction of MI with an area under the ROC curve of 0.77 versus 0.68, and
0.71, respectively, p < 0.01.
Conclusion: By determination of coronary calcifications patients at risk for future MI and CD could be
identified within an asymptomatic high risk group of patients suffering from diabetes mellitus. On the other
hand future events could be excluded in patients without coronary calcifications.
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Background
Diabetes mellitus is one of the most common diseases in
the industrialized countries. The prevalence is expected to
rise over 5% in the next 10 years [1]. Thereby patients with
diabetes mellitus show an increased risk of cardiovascular
events [2]. Independent of concomitant cardiovascular
risk factors diabetic patients possess an up to fourfold risk
of cardiovascular events, equivalent to the risk of nondia-
betic patients with a history of coronary artery disease [3].
In addition, the fatality rate of CAD is significantly higher
in diabetic patients [4]. Overall 65% of diabetic patients
die because of cardiovascular diseases.
To assess the risk of future events in this high risk popula-
tion, several score systems based on concomitant risk fac-
tors and diseases have been introduced. Thereby the
diagnostic accuracy in the prediction of future events is
still limited [5-7]. Beside the scores based on epidemio-
logical studies electron beam computed tomography
offers the possibility to detect and quantify the amount of
coronary calcium (CAC). In histopathologic studies coro-
nary calcifications have shown to be a sensitive marker of
early stages of coronary atherosclerosis [8,9]. Further-
more, the amount of coronary calcifications correlates to
the extent of coronary atherosclerosis and coronary steno-
sis [10,11]. Several studies have already shown the associ-
ation of future cardiovascular events with an elevated
amount of coronary calcifications. In addition, the exclu-
sion of coronary calcification is associated with a strong
negative predictive value for future cardiovascular events.
Still it is questionable, whether the determination of CAC
adds an additional prognostic and clinical value in a high
risk population of patients [12-14]. Therefore, we concen-
trated in this prospective study on asymptomatic patients
suffering from diabetes mellitus and assessed the prognos-
tic value of CAC over an observation period of 8 years. In
addition, the results were compared to conventional mod-
els of risk stratification, the Framingham cardiovascular
risk score, and the UKPDS risk engine [5,15].
Methods
Study protocol
The research protocol was approved by the local Clinical
Institutional Review Board and complies with the declara-
tion of Helsinki. From January 1998 to April 1999 we
asked 938 asymptomatic patients with Diabetes mellitus
type 2 referred to our clinic for a preventive medical check
up to take part in this prospective study. 776 patients
agreed to undergo EBCT scanning and follow up-inter-
view and were included in this study after giving written
consent. All patients had no history of CAD and were
asymptomatic regarding CAD. In addition no signs of
CAD could be found in ECG, stress ECG and echocardiog-
raphy. Thereby Stress ECG was not available in 18
patients, echocardiography in 12 patients.
Risk factors
Diagnosis of diabetes mellitus was assured in all patients
by determination of glucose in fasting state as described
by the definition of the World Health Organization [16].
Additional cardiovascular risk factors were assessed by
personal interview and screening of medical records. In
every patient arterial blood pressure (three times after 10
minutes rest), LDL cholesterol level, HDL cholesterol
level, and triglyceride level were determined in the fasting
state in our hospital. Arterial hypertension was defined as
systolic blood pressure above 140 mmHg or diastolic
blood pressure above 90 mmHg. Family history was
measured by personal interview and defined as coronary
heart disease in male first degree relative <55 years; coro-
nary heart disease in female first degree relative <65 years.
Based on cardiovascular risk factors and concomitant dis-
eases we calculated the risk for future cardiac death or
nonfatal myocardial infarction based on the Framingham
population and the UKPDS risk engine [17]. According to
both scores patients were assigned to one of the following
risk groups: low risk (event rate < 10%), intermediate risk
(event rate > 10% and < 20%), and high risk (event rate >
20%).
EBCT scanning procedure
EBCT scans were performed using the Imatron C-150 XP
scanner (Imatron, South San Francisco, California, USA)
in the high resolution mode. Images were acquired ECG-
triggered at 80 percent of the R-R interval during one end-
inspiratory breathholding period. Slice thickness was 3
mm, scan time 100 ms. A field of view of 26 cm was cho-
sen. A total of 40 slices were obtained covering the whole
heart. Coronary calcifications were defined as lesions with
a density > 130 HU in more than 2 adjacent pixels. For
quantification of coronary calcium we calculated the Agat-
ston score, which is the product of the lesions area and a
factor from 1 to 4 representing the peak density of the
lesion [18]. EBCT scans were evaluated without knowl-
edge of patient's characteristics. The patients were una-
ware of their Agatston score.
Clinical follow-up
Study patients were contacted after an observation time of
8 years after the CT scan. An interims analysis was per-
formed after 4 years. Cardiovascular events were assessed
using a standardized telephone interview. In case of hos-
pital admission or further cardiologic examinations the
patient's medical records were reviewed for complaints of
chest discomfort, dyspnea, myocardial infarction, and
coronary revascularization.
Clinical endpoints
The study endpoints were cardiac death (CD) and myo-
cardial infarction (MI) as hard events and coronary revas-BMC Cardiovascular Disorders 2008, 8:27 http://www.biomedcentral.com/1471-2261/8/27
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cularization (CR), coronary artery bypass graft (CABG) or
percutaneous transluminal coronary angioplasty (PTCA),
as soft events. MI was defined as the presence of at least 2
of the following: prolonged chest pain leading to hospital
admission, specific ECG changes, elevation of serum crea-
tine kinase levels up to twice the upper limit with an ele-
vated creatine kinase-MB fraction or troponin level. Death
due to coronary artery disease was considered when death
was proved to be due to coronary atherosclerosis by
autopsy, occurred within 1 hour after onset of prolonged
severe chest pain, or occurred during hospital admission
because of MI. Coronary interventions had to be con-
firmed by reports of the performing physician.
Statistics
Statistical analyses were performed using the SPSS soft-
ware package (version 10.0, SPSS Inc. Chicago, Illinois).
Agatston score was expressed as mean score ± standard
deviation except where indicated. Because of the non-nor-
mality, statistical analysis was performed on the base 10
log of the transformed Agatston score + 1. To compare
score values in different risk groups, we used the Wilcoxon
signed rank test for unpaired data. A p-value under 0.05
was considered to indicate statistical significance. We per-
formed univariate Cox regression analysis to calculate
hazard ratio and 95 percent confidence interval of cardiac
death and MI in dependence of cardiovascular risk factors
(patients without cardiovascular risk factors served as the
reference group), age, sex, and Agatston score (patients
without coronary calcifications served as the reference
group). To account for the inflation of the type I error due
to multiple testing, we performed the Bonferroni adjust-
ment. The significance level was set at 0.05/4 = 0.0125
and 0.05/2 = 0.025.
In addition, Cox proportional hazards survival curves
showing the estimated event free survival determined by
the Cox regression model were calculated for patients in
different score categories [19]. The results were adjusted
for differences in age and sex. To verify the assumption of
proportional hazards we performed an analysis of the
Kaplan-Meier curves as described by Hosmer and Leme-
show.
To demonstrate the discriminatory power of Agatston
score, UKPDS score, and Framingham score in prediction
of cardiovascular events the area under the receiver-oper-
ating characteristic (ROC) curve was determined. ROC
curve analysis was performed as follows: Sensitivity was
plotted as a function of the false positive rate (1-specifi-
city) for predicting cardiovascular events. An area under
the curve of 1.0 represents a perfect test with 100 percent
sensitivity and 100 percent specificity, whereas an area of
0.5 represents a random discrimination. Areas under the
curve above 0.7 might indicate a reasonably good clinical
test in combination with a sufficient diagnostic accuracy
(sensitivity, specificity, negative and positive predictive
value). Different ROC curves were compared using the
method of Hanley and McNeil [20].
Results
716 individuals (430 men and 280 women, age 55.2 ±
15.2 years) of the initially 776 included patients com-
pleted the follow up. 32 patients died of non-cardiac
death, 28 patients could not be contacted for a follow-up
examination. There was no difference in age, risk factor
distribution, and Agatston score between these patients
that completed the follow up and those that did not finish
the study. The mean observation time was 8.1 ± 1.1 years
(range 7.1 to 9.4 years). Patients' characteristics and ther-
apies are given in table 1. The mean number of risk factors
per person was 3.0 ± 1.3 in men and 2.8 ± 1.1 in women
(range 1 – 5), see table 1.
Distribution of Agatston score
The mean Agatston score was 288 ± 153 (range 0 – 2849,
median 576, quartile rank 145 and 877), 319 ± 187 for
men, and 241 ± 157 for women, p = 0.02. The score
increased from 34 ± 11 (range 0 – 99) for patients under
40 years to 418 ± 178 (range 0 – 2849) for patients older
than 70 years. In 107 patients coronary calcifications
could be excluded (score 0), 302 patients showed an Agat-
ston score above 400. In all age groups the mean score in
men was significantly higher than in women. In patients
with additional arterial hypertension (252 ± 160, range 0
– 701, p = 0.03), and hyperlipidemia (439 ± 256, range 0
– 699, p = 0.01) the average Agatston score was signifi-
cantly higher than in patients without additional cardio-
vascular risk factors (124 ± 74, range 0 – 430).
Cardiac events
36 patients died from CD (0.6% annualised rate), 40
patients suffered from MI (0.7% annualised rate) and 87
patients (64 patients PTCA and 23 patients CABG) under-
went coronary revascularization (1.5% annualised rate).
There was no significant difference between men and
women in all event rates, p = 0.12
No patient with exclusion of cardiovascular calcifications
suffered from MI or CD during the observation period,
only two patients with exclusion of coronary calcifications
underwent coronary revascularization. The event rates of
patients with exclusion of coronary calcifications were sig-
nificantly lower compared to patients with coronary calci-
fications, p = 0.009, see table 2. In patients with scores
above 400 the annualised rates were significantly higher
for all events (p = 0.011).
Figure 1 shows the association between calcium score cat-
egories and event free survival, the results were adjustedBMC Cardiovascular Disorders 2008, 8:27 http://www.biomedcentral.com/1471-2261/8/27
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for differences in age and sex. The cumulative incidence
increased continuously form 3.9% for patients with scores
between 0 – 10 to a cumulative incidence of 42.7% for
patients with scores above 400.
Scores in patients with MI or CD
The mean Agatston score of patients that died from CD or
suffered from MI was significantly higher than in patients
without cardiovascular events, 475 ± 208 compared to
236 ± 199, p = 0.009. In addition, patients that underwent
CR showed a significantly higher Agatston score of 447 ±
228 compared to patients without cardiac event, 236 ±
199, p = 0.007. Framingham risk score and UKPDS score
were significantly higher in patients with cardiovascular
events. There was no significant difference in age or aver-
age number of risk factors between patients with or with-
out cardiac events (table 2).
Figure 2 depicts the distribution of Framingham score,
UKPDS score, and Agatston score in patients with MI.
Table 1: Baseline characteristics of 716 patients included in the study
all men women
number (n) 716 430 286
age (years) 55.2 ± 15.2 55.5 ± 15.2 54.8 ± 15.2
no additional risk factor, n (%) 143 (20) 83 (20) 60 (21)
arterial hypertension, n (%) 372 (52) 249 (58) 123 (43)
treated, BP < 140/90 n (%) 125 (17) 77 (18) 48 (17)
treated, BP > 140/90 n (%) 140 (20) 96 (22) 44 (15)
untreated, BP > 140/90 n (%) 107 (15) 76 (18) 31 (11)
hyperlipidemia or statin therapy, n (%) 301 (42) 184 (44) 117 (41)
statin therapy, cholesterol < 5 mmol/l n (%) 99 (14) 61 (14) 38 (13)
statin therapy, cholesterol > 5 mmol/l n (%) 124 (17) 70 (16) 54 (19)
untreated, cholesterol > 5 mmol/l n (%) 78 (11) 53 (12) 25 (9)
MI in family history, n (%) 451 (63) 271 (63) 186 (65)
smoking, n (%) 243 (34) 151 (35) 94 (33)
HbA1c (%) 7.5 7.6 7.5
average number of risk factors 2.9 3.0 2.8
body mass index (kg/m2) 27.1 ± 6.1 28.3 ± 5.8 25.0 ± 4.9
duration of Diabetes (years) 6.5 ± 2.3 6.4 ± 2.2 6.6 ± 2.3
microalbuminuria n (%) 64 (9) 41 (9) 23 (8)
proteinuria n (%) 41 (6) 25 (6) 16 (6)
peripheral neuropathy n (%) 104 (15) 60 (14) 44 (15)
retinopathy n (%) 145 (20) 90 (21) 55 (19)
atrial fibrillation n (%) 95 (13) 61 (14) 24 (12)
insulin only n (%) 105 (15) 62 (15) 43 (15)
insulin + oral agent n (%) 109 (15) 70 (16) 39 (14)
oral agent only n (%) 502 (70) 298 (69) 204 (71)
Table 2: Event rates for coronary revascularisation (CR), myocardial infarction (MI), and cardiac death (CD) in all patients, patients 
with Agatston score 0, and Agatston score above 400: Total number of events during observation period and annualised rate
All patients no event CR MI + CD all events
n n n % per year n % per year n % per year
Patients (n) 716 553 87 1.5 76 1.3 163 2.8
men (n) 430 332 53 1.5 45 1.3 98 2.8
Women (n) 286 224 31 1.3 31 1.3 62 2.7
S c o r e  0 1 0 7 1 0 520 . 200 . 020 . 2
Score > 400 302 165 71 2.9 * 66 2.7 * 137 5.6 *
number of risk factors 2.9 2.7 2.8 2.9 2.9
age (years) 55.7 ± 13.0 55.3 ± 13.2 57.4 ± 12.4 56.9 ± 13.1 57.1 ± 12.9
Agatston score 288 ± 153 236 ± 199 447 ± 228 * 475 ± 208 * 459 ± 219 *
Framingham risk score 9.6 ± 3.4 8.6 ± 3.4 13.1 ± 3.9 * 13.7 ± 4.1 * 13.3 ± 3.8 *
UKPDS Score 9.6 ± 2.8 8.4 ± 3.6 13.7 ± 4.0 * 14.0 ± 4.3 * 13.8 ± 4.1 *
Score parameters (UKPDS score, Framingham score, and Agatston score) in patients with and without cardiovascular events * indicates a significant 
higher event rate and a significant difference in score, respectively, † indicates a significant lower event rate (p < 0.05) compared to the event rate 
in all patients (first row).BMC Cardiovascular Disorders 2008, 8:27 http://www.biomedcentral.com/1471-2261/8/27
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According to Framingham score (57%) and UKPDS score
(60%) most patients with MI were considered as interme-
diate risk patients. 34% and 36%, respectively, were
assigned to the high risk group. 9% (Framingham score)
and 4% (UKPDS score) of patients with MI would have
been considered as low risk patients. The proportion of
patients with MI and an Agatston score above the 75th per-
centile added up to 86%, 13% had an Agatston score
below the 75th and above the 25th percentile, and 1% had
an Agatston score below the 25th percentile.
Relative Risk of MI
The relative risk for MI and CD in dependence of addi-
tional cardiovascular risk factors was lowest for patients
with smoking, 2.14, and increased with 2.47 for patients
with arterial hypertension up to 2.75 for patients with
hyperlipidemia. The relative risk for MI and CD was
increased in patients with diabetes associated diseases,
1.76 in patients with retinopathy, 1.36 in patients with
microalbuminuria, and 1.76 in patients with proteinuria.
An increase of Framingham score and UKPDS score was
associated with an increase of relative risk, 6.0 for a ten
unit increase of Framingham score and 7.1 for a ten unit
increase of UKPDS score. The highest relative risk of 14.2
for MI or CD was calculated for patients with Agatston
scores above 400 (table 3). In addition table 4 shows the
relative risk of cardiovascular events for different catego-
ries of calcifications: We found a continuously increasing
risk of cardiovascular events with increasing calcium
scores, the relative risk increased from 3.1 (2.8 women)
for patients with scores from 0 – 10 to 32.8 (50.0 women)
for patients with scores above 400.
To illustrate the diagnostic accuracy of UKPDS score,
Framingham score and Agatston score for the prediction
of MI, ROC curves were calculated and the area under the
ROC curve representing the diagnostic threshold was
determined. The area under the ROC curve of the Agatston
score was significantly larger than the area under the ROC
curves of UKPDS score and Framingham score (0.76, con-
fidence interval 0.73 – 0.82, compared to 0.63, confi-
Table 3: Univariable Cox proportional hazards model predicting 
the combined primary endpoint myocardial infarction and 
cardiac death (MI and CD) in dependence of cardiovascular risk 
factors and Agatston scores above the 75. percentile
relative risk 95% CI p value
no risk factors 1 - -
arterial hypertension 2.47 * 2.21–2.81 0.005
smoking 2.14 * 2.01–2.33 0.005
hyperlipidemia 2.75 * 2.49–3.19 0.006
microalbuminuria 1.36 1.30–1.47 0.151
proteinuria 1.71 * 1.56–1.97 0.018
familiy history 1.45 * 1.28–1.73 0.012
duration of diabetes 1.51 1.39–1.69 0.013
retinopathy 1.76 * 1.60–2.04 0.013
HbA1C 1.89 * 1.69–2.19 0.009
Framingham risk score 6.0 * 4.9–7.8 0.004
UKPDS Score 7.1 * 6.0–8.9 0.003
Agatston score > 400 14.2 * 12.7–16.8 0.001
* indicates a significant difference (p < 0.05) compared to the patient 
group without cardiovascular risk factors and without coronary 
calcifications, respectively.
Cox proportional hazards survival curves showing the cumu- lative event free survival for patients with scores from 0–10,  11–100, 101–400, and above 400 Figure 1
Cox proportional hazards survival curves showing 
the cumulative event free survival for patients with 
scores from 0–10, 11–100, 101–400, and above 400.
Risk stratification according to UKPDS score, Framingham  score, and Agatston score in patients suffering from myocar- dial infarction (n = 76) Figure 2
Risk stratification according to UKPDS score, Fram-
ingham score, and Agatston score in patients suffer-
ing from myocardial infarction (n = 76).BMC Cardiovascular Disorders 2008, 8:27 http://www.biomedcentral.com/1471-2261/8/27
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dence interval 0.59 – 0.66, and 0.66, confidence interval
0.62 – 0.68, p = 0.03, figure 3)
Discussion
The aim of this study was to evaluate the predictive value
of coronary calcifications in a high risk population,
patients suffering from diabetes, over a long-term obser-
vation period of 8 years. The results were compared to
conventional risk stratification using Framingham score
and UKPDS score. On study entry all patients were not
only asymptomatic, but also showed negative results in
ECG, stress ECG, and echocardiography. Thus, further
diagnostics or interventions were not indicated following
the present guidelines and the study population could be
considered a homogenous collective without evidence of
coronary artery disease on study entry.
The distribution of risk factors and diabetes associated
diseases is similar to study populations in prior studies
examining cardiovascular risk stratification in patients
with diabetes mellitus [16,21]. Compared to prior studies
evaluating the predictive value of coronary calcifications
the number of risk factors per person is increased, which
can be explained by the preselection due to concentrating
on patients with diabetes referred for a cardiological
examination [12,13,22].
Distribution of coronary calcifications
It has been discussed, if cardiovascular risk stratification
can be improved by determination of coronary calcium in
populations with an already increased risk for cardiovas-
cular events such as patients with diabetes mellitus or eld-
erly patients. The average score of 288 ± 153 in this study
was higher compared to non-diabetic populations
described by Hoff et al., Rumberger et al., and Schmer-
mund et al. [23,24,22]. Still we could find a similar score
distribution within our population: As described in sev-
eral previous publications the mean Agatston score
ROC curves and area under the curve of UKPDS score,  Framingham score, and Agatston score for the prediction of  myocardial infarction Figure 3
ROC curves and area under the curve of UKPDS 
score, Framingham score, and Agatston score for the 
prediction of myocardial infarction.
Table 4: Cox proportional hazards model predicting the combined primary endpoint (MI and CD) in different score groups for men a) 
and women b) adjusted for cardiovascular risk factors
a) men
Score number of events number of patients event rate (%) hazard ratio (95% CI) p value
0–10 2 63 3.1 1
11–100 8 80 10.0 1.9 (1.5–2.5) * 0.04
101 – 400 23 86 26.7 5.4 (4.5–7.0) * 0.02
> 400 66 201 32.8 9.5 (8.0–11.9) * 0.01
All 99 430 10.8
b) women
Score number of events number of patients event rate (%) hazard ratio (95% CI) p value
0–10 1 74 2.8 1
11–100 5 82 6.1 1.6 (1.1–2.3) * 0.02
101 – 400 22 60 36.7 5.2 (4.0–6.9) * 0.02
> 400 35 70 50.0 14.1 (12.0–16.8) * 0.01
All 62 286 9.9
* indicates a significant difference (p < 0.05) compared to the patient group without coronary calcifications.BMC Cardiovascular Disorders 2008, 8:27 http://www.biomedcentral.com/1471-2261/8/27
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increased with patients' age and was significantly higher
in male than in female patients. As expected, an increase
of coronary calcifications in patients with additional car-
diovascular risk factors could be observed. Within these
subgroups a further discrimination of patients by calcium
score was possible: In each group patients with a score of
zero could be found, whereas in patients without addi-
tional risk factors scores up to 430 could be detected.
These findings comply not only with studies in non-dia-
betic populations [25,12], but a similar score distribution
could be found in other studies examining patients with
an elevated risk of cardiovascular event and elevated cal-
cium scores: Vliegenthart et al. achieved equivalent results
in elderly patients, Anand et al. in diabetic patients
[26,21].
Therefore, an additive value of coronary calcium for an
improved risk stratification can be assumed in diabetic
individuals.
Cardiovascular events
This assumption is being supported by the significantly
higher event rate for CR, MI, and CD of patients with an
Agatston score above 400. In addition future MI or CD
could be excluded in patients without coronary calcifica-
tions (table 2). This could be observed independently of
concomitant risk factors in all age groups indicating that
coronary calcifications reflect the patient's individual
extent of atherosclerosis. Therefore, coronary calcifica-
tions can be considered as an adequate tool for the indi-
vidual prediction of cardiovascular events and might be
superior to conventional risk stratification.
The high accuracy of coronary calcifications is expressed
by the score distribution in patients that suffered from MI
during the observation period. Although we found signif-
icantly higher Framingham scores and UKPDS scores in
patients with MI the risk stratification using the Agatston
score was superior to Framingham score and UKPDS
score: Whereas only 34% and 36% of patients with MI
were classified as high risk patients according to Framing-
ham score and UKPDS score, 85% of patients with MI
were considered as high risk patients according to Agat-
ston score. Most patients with MI, 57% and 60%, were
classified as patients with an intermediate risk by Fram-
ingham score and UKPDS score. The score distribution in
patients with MI was thereby comparable to prior studies
in non-diabetic populations examined by Achenbach et
al. and Becker et al. [12,25].
The strong correlation between coronary calcium and
future cardiovascular events is also expressed by the
increasing relative risk in different score groups. The rela-
tive risk in dependence of elevated Agatston score levels
was significantly higher than the relative risk of conven-
tional cardiovascular risk factors, diabetes associated dis-
eases, or Framingham and UKPDS score (see table 3 and
4).
The high diagnostic accuracy of the Agatston score is also
shown by the high negative predictive value: In all 107
patients with exclusion of coronary calcifications future
cardiovascular events could be excluded. Thus, the present
study with a long-term observation period in diabetic
individuals could confirm the results in prior studies by
Greenland et al, Achenbach et al., and Anand et al.
[27,12,21].
In addition, the significantly higher discriminatory power
of the Agatston score for the prediction of MI is shown by
the significantly larger area under the ROC curve of the
Agatston score compared to Framingham and UKPDS
score (0.76 versus 0.63 and. 0.66, respectively, p = 0.03).
Limitations
The study population consisted of patients with diabetes
sent to our institution for a preventive medical check up.
Therefore, the collective can not be considered as an unse-
lected population. Still it can be regarded as a homoge-
nous population without signs of CAD on study entry, as
ECG, stress ECG, and echocardiography showed regular
findings. All patients received an equivalent treatment
according to current guidelines. And it might be just these
patients with diabetes mellitus sent for further diagnostics
that profit most from improved risk stratifications.
Even if the exclusion of future cardiovascular events by
exclusion of coronary calcifications seems to be possible,
it is still questionable, whether a reduction of the current
prophylactic therapy in these patients is advisable. Rather
a reduction of further examinations e.g. myocardial scin-
tigraphy or coronary angiography could result from an
exclusion of coronary calcifications.
Still it has to be determined, whether the detection of cor-
onary calcification can help to establish more efficient
therapies and diagnostics in patients with diabetes.
This study was performed using the EBCT, which is hardly
available today. It has already been shown, that an equiv-
alent quantification of coronary calcifications is possible
by multislice computed tomography [28,29].
Conclusion
Within a diabetic population, patients with a high risk for
future MI and CD could be identified by the determina-
tion of coronary calcifications independent of concomi-
tant cardiovascular risk factors. Thereby the Agatston score
showed a higher diagnostic accuracy in predicting MI
compared to Framingham risk score or UKPDS risk score.BMC Cardiovascular Disorders 2008, 8:27 http://www.biomedcentral.com/1471-2261/8/27
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The exclusion of coronary calcifications allowed the exclu-
sion of future cardiovascular events within a long term
observation period of 8 years.
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